These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26071390)

  • 1. The incidence of Trichomonas vaginalis infection in women attending nine sexually transmitted diseases clinics in the USA.
    Alcaide ML; Feaster DJ; Duan R; Cohen S; Diaz C; Castro JG; Golden MR; Henn S; Colfax GN; Metsch LR
    Sex Transm Infect; 2016 Feb; 92(1):58-62. PubMed ID: 26071390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.
    Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA
    Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Risk Factors of Trichomonas vaginalis Among Female Sexual Workers in Nairobi, Kenya.
    Lockhart A; Senkomago V; Ting J; Chitwa M; Kimani J; Gakure H; Kwatampora J; Patel S; Mugo N; Smith JS
    Sex Transm Dis; 2019 Jul; 46(7):458-464. PubMed ID: 31194717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia.
    Garland SM; Tabrizi SN; Chen S; Byambaa C; Davaajav K
    Infect Dis Obstet Gynecol; 2001; 9(3):143-6. PubMed ID: 11516062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity?
    Magnus M; Clark R; Myers L; Farley T; Kissinger PJ
    Sex Transm Dis; 2003 Nov; 30(11):839-43. PubMed ID: 14603092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptima
    Bruni MP; Freitas da Silveira M; Stauffert D; Bicca GLO; Caetano Dos Santos C; da Rosa Farias NA; Golparian D; Unemo M
    Sex Transm Infect; 2019 Mar; 95(2):129-132. PubMed ID: 30154157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
    Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
    Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional analysis of
    Bochner AF; Baeten JM; Rustagi AS; Nakku-Joloba E; Lingappa JR; Mugo NR; Bukusi EA; Kapiga S; Delany-Moretlwe S; Celum C; Barnabas RV;
    Sex Transm Infect; 2017 Nov; 93(7):520-529. PubMed ID: 28377421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichomonas vaginalis: underdiagnosis in urban Australia could facilitate re-emergence.
    Lusk MJ; Naing Z; Rayner B; Rismanto N; McIver CJ; Cumming RG; McGeechan K; Rawlinson WD; Konecny P
    Sex Transm Infect; 2010 Jun; 86(3):227-30. PubMed ID: 19880969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.
    Khan A; Fortenberry JD; Juliar BE; Tu W; Orr DP; Batteiger BE
    Sex Transm Dis; 2005 Apr; 32(4):260-4. PubMed ID: 15788928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.
    Guffey MB; Richardson B; Husnik M; Makanani B; Chilongozi D; Yu E; Ramjee G; Mgodi N; Gomez K; Hillier SL; Karim SA;
    Sex Transm Infect; 2014 Aug; 90(5):363-9. PubMed ID: 24898857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.
    Metsch LR; Feaster DJ; Gooden L; Schackman BR; Matheson T; Das M; Golden MR; Huffaker S; Haynes LF; Tross S; Malotte CK; Douaihy A; Korthuis PT; Duffus WA; Henn S; Bolan R; Philip SS; Castro JG; Castellon PC; McLaughlin G; Mandler RN; Branson B; Colfax GN
    JAMA; 2013 Oct; 310(16):1701-10. PubMed ID: 24150466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
    Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
    Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease prevalence in women attending the STD clinic in Mumbai (formerly Bombay), India.
    Divekar AA; Gogate AS; Shivkar LK; Gogate S; Badhwar VR
    Int J STD AIDS; 2000 Jan; 11(1):45-8. PubMed ID: 10667900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine testing of Mycoplasma genitalium and Trichomonas vaginalis.
    Jenniskens ML; Veerbeek JH; Deurloo KL; van Hannen EJ; Thijsen SF
    Infect Dis (Lond); 2017 Jun; 49(6):461-465. PubMed ID: 28301989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation study of the Becton-Dickinson ProbeTec Qx (BDQx)
    Tipple C; Rayment M; Mandalia S; Walton L; O'Neill S; Murray J; O'Riordan A; Rebec M; Harrington L; Jones R; Wilkinson D
    Sex Transm Infect; 2018 Aug; 94(5):334-336. PubMed ID: 28108699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichomonas vaginalis Prevalence and Correlates in Women and Men Attending STI Clinics in Western Canada.
    Gratrix J; Plitt S; Turnbull L; Smyczek P; Brandley J; Scarrott R; Naidu P; Bertholet L; Chernesky M; Read R; Singh AE
    Sex Transm Dis; 2017 Oct; 44(10):627-629. PubMed ID: 28876319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.